Skip to the page

Data / Form D filings / Novascope Biochips Inc.

Novascope Biochips Inc.: Form D filings

Novascope Biochips Inc., a technology company in Scarsdale, NY, filed 2 Form D notices with the SEC in 2023. The latest, on April 11, 2023, reports $104,928 sold of a $104,928 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
20 OXFORD RD, Scarsdale, NY, 10583
Phone
(949) 245-4694
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1965219

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 11, 2023New notice$104,928$104,9281Mar 27, 2023sec.gov
Feb 9, 2023New notice$150,000$150,0001Feb 1, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Yueh Hsiang TsaiExecutive Officer, Director

Other technology companies in New York that filed recently

Every Form D from the week of Apr 10, 2023 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Novascope Biochips Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.